



Structured Exercise in Cancer Survivors: Is it Enough for Neural, Mental Health 
and Well-being? 
 
PETER SMOAK†1, VICTORIA FLORES†1, NICHOLAS HARMAN†2, JONATHON LISANO†1, 
REID HAYWARD‡2, and LAURA K. STEWART‡1  
 
1School of Sport and Exercise Science, University of Northern Colorado, Greeley, CO, USA; 
2University of Northern Colorado Cancer Rehabilitation Institute, Greeley, CO, USA 
 
Boldface denotes dual first authorship, †Denotes graduate student author, ‡Denotes professional author  
 
ABSTRACT 
International Journal of Exercise Science 14(3): 162-176, 2021. The purpose of this cross-sectional study 
was to explore physical activity, depression, fatigue, and quality of life (QOL), and their relationship to brain-
derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in cancer survivors enrolled in a structured 
exercise program. Participants were recruited into two groups: in-treatment (IT), currently receiving chemotherapy 
and/or radiotherapy, and out of treatment (OT), not undergoing therapy. Participants wore accelerometers for 7 
days and completed cardiorespiratory fitness, muscular strength, and depression, fatigue, and QOL assessments. 
Circulating BDNF and NGF concentrations were obtained using enzyme-linked immunosorbent assays. Thirty-two 
participants (IT: n = 13, OT: n = 19) with an average age of 63 years and BMI of 27.5, spent 78% of their waking 
hours engaged in sedentary behavior outside of exercise training. Significant correlations were observed between 
light physical activity (LPA) outside of exercise training and QOL in IT (r = 0.626, p = 0.030), and fatigue in OT (r = 
0.553, p = 0.021). Moderate to vigorous physical activity (MVPA) outside of exercise training significantly correlated 
with leg press strength (r = 0.700, p = 0.008) in IT, and cardiorespiratory fitness (r = 0.440, p = 0.013) when groups 
were combined. Concentrations of NGF did not differ between groups, and in IT, BDNF was positively related to 
LPA outside of training and was significantly lower (87 ± 28.5 pg/mL) than in OT (137 ± 54 pg/mL; p=0.010). While 
structured exercise programs should focus on improving cardiorespiratory fitness and muscular strength during 
exercise training, these programs should consider physical activity outside of training, if well-tolerated, to 
potentially further lower fatigue and improve QOL in cancer survivors. 
 




Cancer is the second leading cause of death in the United States. Although cancer treatments 
have reduced cancer prevalence and mortality rates, by the year 2030, approximately 22.1 
million individuals will be living with a history of cancer (38). Despite improvements in survival 
beyond the initial cancer diagnosis, the risk of developing additional comorbidities such as type 
2 diabetes and other chronic diseases can be as high as 18.5 times greater in cancer survivors (9, 
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23). Furthermore, cancer survivors have up to a 3.6 times greater chance of dying from 
cardiovascular disease when compared to non-cancer populations (9, 23).  
 
In addition to these long-term health risks, which may be related to side effects from surgery, 
radiation, or chemotherapy, cancer survivor motivation for physical activity and exercise is 
reduced (8). Only 30% of cancer survivors are physically active, with the other 70% achieving 
less than the recommended 150 minutes of physical activity per week set forth by the American 
College of Sports Medicine (ACSM) (7, 50).  
 
The benefits of regular, structured exercise may help offset the risks of chronic physical 
inactivity, help cancer survivors overcome feelings related to fatigue (20, 35), and significantly 
reduce the risk of other chronic diseases (31). Consequently, structured exercise programs aimed 
at reducing physical inactivity and improving quality of life (QOL) are becoming more common 
(15). These programs are associated with improvements in body composition, cardiorespiratory 
fitness, muscular strength and endurance, QOL, cancer-related fatigue, sleep disturbances, and 
anxiety and depression in individuals with a variety of cancers (31). However, it is important to 
note that achieving the recommended 150 minutes of physical activity per week through a 
structured exercise program may not be enough to improve all aspects of well-being. In fact, 
individuals enrolled in structured exercise programs tend to be physically active during training 
but may be unaware of time spent in sedentary behavior such as long periods of sitting and/or 
idleness outside of their training (52).  
 
The mechanisms associated with improvements in physical fitness as the result of exercise have 
been identified (11); however, much less is known about the effects of exercise on neural health. 
Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), proteins responsible 
for brain plasticity, regulate the degree of neurogenesis and subsequent changes in cognition 
and emotion from exercise (33). Higher concentrations of BDNF are associated with improved 
cognition and mood (24, 27), while lower concentrations are associated with the presence of 
clinical depression (29, 43). In clinically depressed and cancer populations, both chronic aerobic 
and resistance training increase BDNF concentrations (29), and reduce depression-like 
symptoms (28). Additionally, patients with neurodegenerative disorders have low 
concentrations of NGF, which is correlated with reduced neurogenic inflammation, a necessary 
response to initiate neurogenesis (32). Some evidence suggests exercise interventions 
significantly increase concentrations of NGF to aid in neuronal turnover in healthy populations, 
but diseased populations with multiple sclerosis and autism do not experience a significant 
change (32). In those with metabolic disorders, exercise increases NGF concentrations (2, 10). 
However, these studies did not include cancer survivors, nor do they measure total physical 
activity defined as the sum of daily activities and structured exercise (10, 32). Completing 360 
minutes or more of physical activity per week is inversely related to cancer-specific and all-cause 
mortality risk in long-term cancer survivors, while lower levels of less than 150 minutes and 150 
to 359 minutes per week are inversely related to all-cause mortality only (18). Higher physical 
activity levels correlate with reduced cognitive impairment (55). Depending on cancer and 
treatment type, 35% of cancer survivors will continue to experience cognitive impairment years 
following treatment (25), suggesting the need for more physical activity. However, no studies 
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have examined the relationship between physical activity outside training in combination with 
an exercise intervention for cancer survivors on BDNF and NGF concentrations. 
 
The purpose of the present study was to examine the potential importance of physical activity 
behaviors outside of structured exercise training in cancer survivors either in treatment (IT) or 
out of treatment (OT), and whether these behaviors were related to depression, fatigue, and 
QOL. Due to the significant physiological, psychological, and cognitive effects of radiation 
and/or chemotherapy (1), cancer survivors receiving treatment were separated into IT and OT 
groups. This study also explored whether concentrations of BDNF and NGF differed between 
IT and OT, and the relationships of these biomarkers with physical activity intensity, depression, 
fatigue, and QOL. It was hypothesized that IT will be less physically active outside of training. 
It was hypothesized that physical activity, as well as concentrations of BDNF and NGF, will 
negatively correlate with depression, fatigue, and QOL in both IT and OT groups. It was also 





Participants in this study were cancer survivors enrolled in a progressive phase program at the 
University of Northern Colorado Cancer Rehabilitation Institute (UNCCRI). This program 
consists of an individualized exercise prescription specific to each cancer survivor, based on 
diagnosis, stage, and treatment, with the details of the program described elsewhere (5). All 
participants engaged in a 60-minute supervised exercise session 3 days per week for the 
duration of the study. Once agreeing to participate, individuals were separated into two groups; 
IT consisted of individuals currently receiving chemotherapy and/or radiotherapy, and OT 
consisted of individuals that were no longer receiving or had not received chemotherapy and/or 
radiotherapy. Due to the cross-sectional design of this study, all participants completed 
assessments, accelerometry, and blood draws during the last week of their training program. 
All recruitment and assessments were performed over the course of 6 months. Participants were 
excluded if they had chronically high blood pressure, defined as systolic blood pressure greater 
than 160 mmHg, and diastolic blood pressure greater than 100 mmHg, and significant 
cardiovascular disorders including but not limited to serious arrhythmias, cardiomyopathy, 
congestive heart failure, stroke or transient ischemic attacks, peripheral vascular disease with 
intermittent claudication, and acute, chronic, or recurrent thrombophlebitis. Before the 7-day 
accelerometer wear time, participants completed body composition, cardiorespiratory fitness, 
and muscular strength assessments, and after the 7-day period, a blood draw was performed. 
All exercise training and assessments were conducted by Clinical Cancer Exercise Specialists 
and were approved by the University of Northern Colorado Institutional Review Board. 
Informed consent was obtained from all participants. This research was carried out fully in 
accordance with the ethical standards of the International Journal of Exercise Science (39). 
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Protocol 
Body Size and Composition Measurements: Participants completed body size and composition 
assessments. Height was measured using a stadiometer (BSM170, Cerritos, CA) and body mass 
was measured using an InBody scale (InBody Scale, Cerritos, CA). Body mass index (BMI) was 
calculated using mass (kg) / height (m)2. Percent of body fat was measured using an InBody 
scale equipped with an 8-point electrode body composition analyzer (InBodyUSA Cerritos, CA).  
 
Cardiorespiratory Fitness and Strength Assessments: Cardiorespiratory fitness (VO2peak) was 
measured using the UNCCRI treadmill protocol, a graded protocol specifically designed for 
individuals with a history of cancer (48). Muscular strength measures were obtained for the lat-
pull down, chest press, and leg press exercises. Briefly, all participants completed a warm-up 
set consisting of 1 to 5 repetitions for each strength exercise. After 2 minutes of rest, the 
participant was asked to perform the strength exercise to failure. If the load performed was too 
light, they were asked to rest for 2 minutes and repeat the exercise with an increased load until 
failure occurred between 1 to 10 reps. The estimated one-repetition maximum (1RM) for each 
exercise was determined using the Bryzcki equation which estimates 1RM to failure that must 
occur between 1-10 repetitions (6).  
 
Accelerometry: Movement behaviors were evaluated for in-training and non-training times with 
a fitted-accelerometer (Actigraph, WGT3X-BT) worn around the participant's waist for 7 days 
during the last week of their progressive phase program, with epoch intervals of 10 seconds. All 
accelerometer data were analyzed using Actilife software (Actigraph, Pensacola, FL) with 
Freedson cut-points which included less than 1952 accelerometer counts/min for light intensity, 
1952-5724 accelerometer counts/min for moderate intensity, 5725-9498 accelerometer 
counts/min for hard intensity, and more than 9498 accelerometer counts/min for very hard 
intensity (14). Data were separated into different periods based on times during and outside of 
exercise training. In-training sessions included physical activity during the three supervised 
one-hour exercise sessions per week. Non-training time included all waking hours outside of 
the three training sessions per week.  
 
Depression, Fatigue, and QOL Assessments: Participants were asked to complete three paper-based 
questionnaires evaluating depression, fatigue, and QOL at the end of their progressive phase 
program and before accelerometer and fitness assessments. The Beck Depression Inventory 
consisted of 21 questions that measured intensity, severity, and depth of depression in a score 
range of 1 to over 40, with scores of 17 or above indicating a possible need for professional 
treatment (3). The inventory is an accurate self-report measure for the evaluation of depressive 
symptoms in an oncology setting (4). The Revised Piper Fatigue Scale measured behavioral, 
affective, sensory, and cognitive/mood attributes of fatigue on a 0 to 10-point scale, with higher 
values corresponding to severity of fatigue (44). The scale is recognized as an appropriate 
measure for fatigue in cancer patients (44). The modified Ferrans and Powers QOL Index Cancer 
Version III measures satisfaction with health and functioning, psychological aspects, spiritual 
aspects, social and economic aspects, and family aspects. This survey is specifically designed for 
the cancer population and scores range from 0 to 30, with higher values corresponding to greater 
satisfaction (12, 13). 
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Biomarkers of Neural Health: Blood samples were collected following an 8 hour fast in 
ethylenediaminetetraacetic acid vacutainer tubes (Becton, Dickenson and Company, NJ). 
Samples were centrifuged at 2000 g for 11 minutes at room temperature and stored at -80°C. 
Blood plasma was analyzed for concentrations of BDNF and NGF enzyme-linked 
immunosorbent assays (RayBiotech Life, Peachtree Corners, GA) and a plate reader (BioTek 
Instruments, Inc., Winooski, VT). 
 
Statistical Analysis 
Descriptive statistics are reported for all outcome variables and are reported as mean ± standard 
deviation (SD). Unpaired T-tests were performed to evaluate whether differences existed 
between IT and OT with respect to measures of body size, body composition, cardiorespiratory 
fitness, muscular strength, movement behaviors, depression, fatigue, QOL, and concentrations 
of BDNF and NGF. To evaluate effect size between groups, Cohen’s D was used for body 
composition, cardiorespiratory fitness, and muscular strength, as well as the percentage of time 
spent engaged in sedentary behavior, or light, moderate, vigorous, very vigorous physical 
activity, and MVPA during the 7-day wear time. Pearson’s r was used to explore relationships 
between body size, body composition, cardiorespiratory fitness, muscular strength, in-training 
and non-training movement behavior (% sedentary, % light, % moderate, % vigorous, %very 
vigorous, and % MVPA), depression, fatigue, QOL, and concentrations of BDNF and NGF 
within and between groups. All analyses were performed with GraphPad statistical software 




Participants (N = 32) were between 21 and 86 years of age with an average age of 63 ± 14 years 
(Table 1). The IT group (n = 13) consisted of 10 females and 3 males between the ages of 36 and 
77 years, and OT (n = 19) consisted of 9 females and 10 males between the ages of 21 and 86 
years old. Cancers consisted of breast ((n = 11; stage 1 (n = 6), stage 2 (n = 3), and stage 3 (n = 2)), 
prostate cancer ((n = 4; Gleason scale stage 1 (n = 1), stage 3 (n = 1), stage 7 (n = 1), and stage 8 
(n = 1)), lymphomas ((n = 4; stage 2 (n = 2), stage 3 (n = 1), and liquid unstaged (n = 1)), lung (n 
= 3; stage 4), carcinoma ((n = 2; stage 3 (n = 1) and stage 4 (n = 1)), esophageal (n = 1; stage 2), 
hypopharynx (n = 1; stage 2), peritoneal (n = 1; stage 3), endometrial (n = 1; stage 3), multiple 
myeloma (n = 1; un-staged), leukemia (n = 1; stage 2), and sarcoma (n = 1; stage 3). 
 
Table 1. Characteristics of participants. 
Characteristics IT (n = 13) Mean ± SD 
OT (n = 19) 
Mean ± SD p-value Effect Size 
Age, years 62.9 ± 1 63.6 ± 16.5 0.89 0.05 
Height, inch 65.3 ± 2.7 67.0 ± 3.6 0.17 0.52 
Weight, kg 74.2 ± 16.3 67.0 ± 22.4 0.33 0.37 
BMI, kg/m2 26.9 ± 5.3 28.0 ± 6.7 0.62 0.19 
Body Fat, % 35.7 ± 11.5 33.9 ± 9.2 0.62 0.18 
Note: standard deviation (SD); In-treatment group (IT); Out of treatment (OT); Body mass index (BMI).  
No significant differences between groups.  
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Body Size and Composition: When groups were combined, body weight ranged from 42.5 kg to 
141.6 kg with an average weight of 73.1 ± 44.6 kg, and BMI averaged 27.5 ± 6.1 kg/m2 and ranged 
from 16.1 to 46 kg/m2. Body fat percentage, when both groups were combined, ranged from 
14.0 to 52.8% with an average of 34.7 ± 10.1%. There were no significant differences between IT 
and OT with respect to any measure of body size or composition. Although significantly greater 
height (p = 0.001) and less body fat percent (p = 0.0064) were observed in males compared to 
females, there were no other sex differences within IT and OT and when groups were combined 
(Table 1).  
 
Cardiorespiratory Fitness and Muscular Strength: The average VO2peak for all participants was 25.7 
± 8.1 mL/kg and ranged from 11.2 to 38.2 mL/kg, and there were no significant differences 
between groups (Table 2). No VO2peak differences between sexes were observed and there were 
no significant correlations between age and VO2peak. There were no differences between IT and 
OT for all strength measures except for the lat-pull down, where OT values were higher than IT 
values (p = 0.048, d = 0.77; Table 2). There was also a difference between sexes with chest press 
strength (p = 0.0004) and lat-pull down strength (p = 0.001).  
 
Table 2. Cardiorespiratory fitness and muscular strength measures of participants. 
Measure IT (n = 13) Mean ± SD 
OT (n = 19) 
Mean ± SD p-value Effect Size 
VO2peak, mL/kg/min 26.3 ± 8.6 25.3 ± 8.0 0.74 0.12 
Lat-Pulldown, kg 44.1 ± 15.1 58.0± 20.8 0.048 0.77 
Chest Press, kg 34.7± 18.7 41.6 ± 15.0 0.25 0.41 
Leg Press, kg 98.2 ± 45.9 107.6 ± 49.7 0.59 0.04 
Note: Standard deviation (SD); In-treatment (IT); Out of treatment (OT); OT Lat-pull down = significantly higher 
than IT (p = 0.048).  
 
In-Training Physical Activity: Participant training programs consisted of 60-minutes of 
supervised exercise sessions 3 days per week, totaling 180 minutes of structured exercise. When 
groups were combined, participants performed an average of 25.0 ± 10.6% light, 7.8 ± 8.2% 
moderate, 1.2 ± 4.7% vigorous, and 0.04 ± 0.13% very vigorous physical activity, and 9.5 ± 11.9% 
MVPA in their respective training sessions. There were no significant differences between 
groups with respect to physical activity during training times. However, there was a medium 
effect size between IT and OT in the percentage of time spent in sedentary and moderate 
activities (Table 3). There were no differences between sexes either between or within groups.  
When groups were combined, moderate physical activity correlated with the leg curl (r = 
0.382, N = 29, p = 0.041). However, in IT, there were strong positive relationships with respect 
to moderate physical activity and the leg curl (r = 0.689, N = 13, p = 0.009), leg extension (r = 
0.560, N = 13, p = 0.046), and leg press (r = 0.745, N = 13, p = 0.003), very vigorous physical 
activity and lat-pull down (r = 0.746, N = 13, p = 0.003), chest press (r = 0.753, N = 13, p = 0.003), 
row (r = 0.715, N = 13, p = 0.006), and leg press (r = 0.702, N = 13, p = 0.007), and MVPA and the 
leg curl (r = 0.602, N = 13, p = 0.029) and leg press (r = 0.660, N = 13, p = 0.014), and in OT, very 
vigorous physical and chest press (r = 0.381, N = 30, p = 0.038).  
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Table 3. In training physical activity of participants. 
Physical Activity  IT (n = 13) Mean ± SD 
OT (n = 19) 
Mean ± SD p-value Effect Size 
Sedentary, %  70.5 ± 16.5 61.3 ± 17.8 0.16 0.53 
Light, % 22.7 ± 10.0 26.6 ± 11.1 0.33 0.37 
Moderate, % 5.2 ± 6.0 9.7 ± 9.2 0.13 0.59 
Vigorous, % 0.9 ± 1.8 2.0 ± 6.0 0.36 0.25 
Very Vigorous, % 0.04 ± 0.1 0.05 ± 0.1 0.78 0.07 
MVPA, % 6.9 ± 10.0 11.7 ± 13.2 0.29 0.07 
Note: Standard deviation (SD); In-treatment (IT); Out of treatment (OT); Moderate to vigorous physical activity 
(MVPA). There were no significant differences between the groups.  
 
Non-Training Physical Activity: Both groups spent most of their time engaged in sedentary 
behavior during non-training times (Table 4). The portion of time spent engaged in sedentary 
behaviors when groups were combined averaged 78.0 ± 10.0% and ranged from 59.7% to 94.6%, 
which translates to a range of 4,014 to 6,358 minutes out of the average 6,720 minutes spent 
awake outside of the training sessions. Additionally, there were no significant differences 
between groups for any measure of physical activity during non-training times. Both groups 
combined, spent an average of 19.6 ± 9.1% in light physical activity (LPA), 2.3 ± 1.7% in moderate 
physical activity, 0.09 ±0.17% in vigorous physical activity, 0.0 ± 0.008 % in very vigorous 
physical activity, and 2.4 ± 1.8% in MVPA (Table 4). No sex differences were observed in IT for 
non-training movement behavior. Within OT, a difference between the sexes was observed for 
the total time spent engaged in vigorous physical activity; females performed on average 4 
minutes more vigorous activity than males, but no sex differences were observed between 
groups. Additionally, no differences were observed between sexes in any other physical activity 
category in OT.  
 
When groups were combined, there were moderate correlations with VO2peak and both 
moderate physical activity (r = 0.420, N = 32, p = 0.017) and MVPA (r = 0.440, N = 32, p = 0.013). 
There were no significant correlations between strength measures and physical activity when 
groups were combined. However, there were strong positive correlations between leg press and 
moderate physical activity (r = 0.690, N = 32, p = 0.009), and leg press and MVPA (r = 0.700, N = 
32, p = 0.008) in IT outside of their structured exercise program. Conversely, OT had no 
significant relationships between strength measures and physical activity outside of training 
time. 
 
Table 4. Non-training physical activity of participants. 
Physical Activity IT (n = 13) Mean ± SD 
OT (n = 19) 
Mean ± SD p-value Effect Size 
Sedentary, %  79.35 ± 7.94 77.07 ± 11.34 0.54 0.23 
Light, % 17.83 ± 7.38 20.94 ± 10.15 0.36 0.35 
Moderate, % 2.49 ± 1.91 2.23 ± 1.61 0.69 0.15 
Vigorous, % 0.10 ± 0.15 0.09 ± 0.19 0.79 0.06 
Very Vigorous, % 0.00 ± 0.01 0.00 ± 0.01 0.76 0.00 
MVPA, % 2.59 ± 1.99 2.32 ± 1.73 0.69 0.14 
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Note: Standard deviation (SD). In-treatment (IT); Out of treatment (OT); Moderate to vigorous physical activity 
(MVPA). There were no significant differences between the groups. There were no differences between sexes.  
 
Depression, Fatigue, and QOL: When both groups were combined, average Beck, Piper, and QOL 
scores were 6.2, 3.0, and 23.4, and ranged from 0 to 21, 0 to 6.6, and 11 to 28.4, respectively, and 
there were no differences between groups. However, there was a strong positive correlation 
between depression and fatigue (R = 0.620, N = 19, p = 0.005) and a strong negative correlation 
between depression and QOL (R = -0.889, N = 18, p < 0.0001) in OT, while no significant 
correlations were observed in IT. When groups were combined, a positive correlation was 
observed between depression and fatigue (r = 0.529, N = 32, p = 0.002), and strong negative 
correlations were observed between depression and QOL (r = -0.796, N = 30, p < 0.0001) and 
fatigue and QOL (r = -0.563, N = 30, p = 0.001). 
 
Strong negative correlations were also observed between fatigue and VO2peak in IT (r = -0.755, 
N = 13, p = 0.003) and when groups were combined (r = -0.438, N = 32, p = 0.012). Quality of life 
and lat-pull down strength were also positively correlated when groups were combined (r = 
0.364, N = 30, p = 0.048). However, no significant correlations with respect to depression, 
VO2peak, and other strength measures were observed. There were moderate positive 
correlations between LPA and QOL in IT (r = 0.626, N = 12, p = 0.030), LPA and fatigue in OT (r 
= 0.553, N = 17, p = 0.021), and LPA and QOL when groups were combined (r = 0.580, N = 29, p 
= 0.001) outside training times. Light physical activity was also negatively correlated with 
depression when groups were combined (r = -0.380, N = 29, p = 0.001). Moreover, there were no 
significant correlations between moderate, vigorous, and MVPA with depression, fatigue, and 
QOL during training times. 
 
Biomarkers of Neural Health: Average BDNF concentrations in IT (87.0 ± 28.5 pg/mL) were 
significantly less than the average concentrations of BDNF in OT (137.1 ± 54.1 pg/mL; p = 0.010) 
(Figure 1). Plasma BDNF concentrations ranged from 42.4 pg/mL to 131.2 pg/mL in IT, and 62.3 
pg/mL to 247.2 pg/mL in OT. Average NGF concentrations were 4.8 ± 0.5 pg/mL in IT, and 5.3 
± 1.0 pg/mL in OT (Figure 2), and there was no significant difference between groups (p = 0.26). 
Concentrations of NGF ranged from 4.1 pg/mL to 5.4 pg/mL in IT, and 3.9 pg/mL and 7.7 
pg/mL in OT. There were no significant relationships between concentrations of BDNF and 
NGF with respect to any of the health-related fitness measures when IT and OT groups were 
combined. 
 
The IT group had strong positive correlations between LPA and BDNF concentrations (r = 0.673, 
N = 11, p = 0.023) outside of training time, and LPA and BDNF concentrations (r = 0.669, N = 11, 
p = 0.025) during total training time. However, there was a strong negative correlation between 
LPA and NGF concentrations (r = -0.705, N = 10, p = 0.022) during training time. There was also 
a moderate negative correlation between total time spent in vigorous physical activity and NGF 
concentrations (r = -0.538, N = 19, p = 0.018) when groups were combined.  
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Figure 1. Mean BDNF concentrations of participants (N = 32). The vertical axes represent the mean concentration 
of brain-derived neurotrophic factor (BDNF). The horizontal axes represent each group. IT = In treatment, OT = 




Figure 2. Mean NGF concentrations of participants (N = 32). The vertical axes represent the mean concentration of 
nerve-growth factor (NGF). The horizontal axes represent each group. IT = In treatment, OT = out of treatment. No 




In the present study, physical activity outside of structured exercise was significantly correlated 
to neural health, fatigue, and QOL in cancer survivors. Concentrations of BDNF were 
significantly higher in the OT group and significantly correlated to LPA in the IT group. 
Additionally, only higher amounts of LPA outside of structured exercise was significantly 
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Mean plasma BDNF concentrations were 36% higher in the OT group who were, on average, 8 
months removed from cancer treatment, and engaged in 3.1% more LPA than IT. Total mean 
BDNF concentration in the present study was 116 pg/mL, which is 50% lower than mean 
concentrations in healthy older, physically active adults (30), and 211% higher than patients with 
advanced metastatic cancers (26). The discrepancy in BDNF concentration is most likely 
explained by the lingering effects of cancer treatment. Serum BDNF concentration significantly 
decreases in non-active, early-stage breast cancer patients before, during, and after 
chemotherapy (5,423, 5,313, and 4,050 pg/mL, respectively) (41), and before and after breast 
cancer surgery (25,523 and 21,551 pg/mL, respectively) (56). It should be noted that although 
serum BDNF concentration is on average 14 times greater than plasma BDNF, changes in serum 
positively correlate with changes in plasma BDNF (16, 53). 
 
Interestingly, BDNF concentrations were positively correlated with LPA outside of training time 
in IT. This finding is similar to a report demonstrating BDNF concentration is improved with 
gross motor activity involving dynamic stretching, walking through obstacles, and slow 
breathing compared to combined resistance and aerobic training in healthy older adults 60 to 85 
years old (17). The IT group spent about 18% of their outside training time engaged in LPA 
which may have included walking, stretching, or home-based activities. This suggests that low 
intensity exercise may be enough to assist with neural health and well-being in cancer survivors 
receiving cancer treatment and that LPA consisting of a wide variety of activities should be 
encouraged outside of training times. Similarly, a 6-week home-based program demonstrated 
that low to moderate-intensity exercise significantly can improve anxiety and mood in patients 
receiving chemotherapy (34). It is important to note that in healthy men, BDNF concentrations 
do not increase with exhaustive exercise when compared to submaximal exercise (16). Given the 
integral role of BDNF and its neuroprotective effects, it is possible LPA may be more beneficial 
for the psychological well-being of cancer patients receiving treatment compared to MVPA and 
may have added benefits when combined with a structured exercise program. 
 
Plasma NGF concentrations were not different between groups and were negatively correlated 
with LPA during training and vigorous physical activity when training times were combined. 
This relationship suggests circulating concentrations of NGF may not be dependent on high 
levels of exercise intensity. Exercise-related increases in NGF are associated with improved 
spatial memory through cholinergic signaling pathways (19). In preclinical studies, NGF is 
sequestered into the hippocampus following exercise to aid in recovery (19). It is possible that 
exercise-induced NGF production amidst the effects of cancer treatment may have been utilized 
in a cholinergic recovery mechanism and resulted in an undetectable change (19).  
 
Though the cancer survivors in the present study spent a minimal amount of their waking hours 
engaged in activity outside of training sessions, it was significantly, negatively correlated with 
fatigue, and significantly, positively correlated with QOL. Depression and QOL correlated with 
LPA outside of training times when both groups were combined, affirming the positive 
relationship between low-moderate physical activity and emotional well-being while receiving 
therapy (34), and moderate physical activity and QOL in cancer survivors removed from 
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treatment (50). Overall, mean total depression, fatigue, and QOL scores and associations are 
similar to previously reported scores from cancer survivors participating in exercise 
interventions. Mean total depression scores were within the “normal” range of 1-10 (3) and were 
26% lower than depression scores reported from 120 cancer survivors after completing a 3-
month intervention (36). Mean total fatigue fell within the “mild” range of 1-3 (44) and was 50% 
lower than fatigue scores reported in the aforementioned study (36), and 15% lower than scores 
reported from 8 cancer survivors after 10 weeks of the same structured exercise program in the 
present study (45). The variance in fatigue suggests treatment side effects significantly affect 
well-being within the first year of survivorship. In previous studies, cancer survivors were, on 
average, within 30 days of treatment (45), currently receiving chemotherapy and/or radiation 
(36), or within 6 months of completing treatment (36), while the present study assessed cancer 
survivors in and out of treatment. Mean total QOL was 23.4 and similar to a reported mean of 
21.2 in breast cancer survivors one year after treatment (47).  
 
These findings are intriguing especially because cancer survivors in the present study spent 78% 
of their days, including both training and non-training periods, engaged in sedentary behavior, 
and 3% of their waking hours engaged in MVPA. These results are very similar to previous 
reports examining movement behaviors in cancer survivors, in which 78% of waking hours were 
spent engaged in sedentary behavior, and less than 2% was spent engaged in MVPA (46). 
Significantly more sedentary behavior was expected in IT (40); however, despite a moderate 
effect size (d = 0.53), there were no significant differences between groups. The average overall 
time spent in sedentary behavior was also expected to be lower in OT. It is possible that long 
term fatigue, induced by cancer, cancer treatments, training sessions, or a combination of these 
factors, may play a role in the prevalence of sedentary behavior observed throughout the 
continuum of survivorship in the current study. Another possible explanation for this lack of 
activity increase is that cancer survivors may be developing a propensity for sedentary behavior 
during treatment, which persists in subsequent years. A study examining movement behaviors 
of breast cancer survivors for one year following treatment suggested that sedentary time is high 
(78%) but stable after treatment; however, it is important to note that MVPA decreased 
significantly in the year following treatment (46).  
 
The participants of this study completed 180 minutes of structured exercise training, and both 
groups spent an average of 35% (63 minutes) performing physical activity, with 27% (17.2 
minutes) of the 63 minutes in MVPA. When training times and non-training times were 
combined for both groups, the average MVPA was 2.7% of their waking hours, which translates 
to 179.2 ± 135.4 minutes and is 20% more MVPA than recommended per week (54). Furthermore, 
8 out of 13 (62%) subjects in IT and 11 out of 19 (58%) subjects in OT reached the recommended 
150 minutes of MVPA per week. Nonetheless, research suggests that just meeting the current 
MVPA recommendation may not be adequate to counteract the effects of a sedentary lifestyle 
(21). Increased risk related to cancer, treatments, and a sedentary lifestyle, may have a 
combinatorial effect resulting in an increased risk for disease. Some studies suggest this may 
require a higher recommendation for MVPA per week (21). Although participants in the present 
study were idle for the majority of their waking hours during the 7-day period, they still 
engaged in 162 ± 132 minutes of MVPA outside of training times which is 8% more than the 
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recommended 150 minutes of MVPA per week (54). Participants in this study were also similar 
in fitness and strength. There was a moderate relationship between VO2peak and both moderate 
physical activity and MVPA outside of training. This positive relationship has been observed in 
many different populations (49), suggesting that emphasis on improving one or both of these 
components may be helpful for program goals. 
 
There are a few noteworthy strengths and limitations in this study. The main strength of this 
study is that it explores physical activity both during and outside of a structured exercise 
program and the relationship that physical activity in these time periods may have to neural 
health in these cancer survivors. Data show that despite being enrolled in an exercise program, 
the propensity for sedentary behavior is high; however, increasing overall light physical activity 
may improve concentrations of BDNF more than high intensity physical activity. A limitation 
of this study is the small sample size that consisted of a variety of cancer types, stages, and 
treatments. However, this limitation may also be a strength because it provides a realistic 
representation of cancer survivors currently enrolled in rehabilitation programs. Additionally, 
during training sessions, participants spent the most time in sedentary (or in sitting) behaviors. 
The Actigraph accelerometer worn around the waist is limited in its ability to capture movement 
performed while in a seated or lying down position, such as a leg press or chest press (51). 
 
In conclusion, this study showed that cancer survivors, both in and out of treatment, are 
spending nearly 78% of their waking hours in sedentary behavior even while participating in a 
structured, supervised exercise intervention. This is in stark contrast to the normal healthy 
population which spends on average 55% of their waking hours in sedentary behavior (37). With 
sedentary behavior now considered a health risk, this may be a cause for concern in the cancer 
survivor population as this could lead to the development of secondary diseases including 
cardiovascular and metabolic disease (9, 21-23, 42). Our results suggest that structured exercise 
programs for cancer survivors should encourage participants to engage in a range of additional 
activities outside of training times to promote the full range of health benefits associated with 
regular physical activity. Additionally, the neuroprotective effect of BDNF may be enhanced 
with LPA which may be more beneficial for the psychological well-being of cancer patients 
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